ANET
Arista Networks, Inc.Close $140.49EOD onlyThis page reflects ANET options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.
Historical consensus-supported lens with full content, report chain context, and metric rail.
Outlook
Bearish with a strong gravitational pull toward $105-$115 support. Confidence: 3/10. Negative GEX (-$7M) suggests trending downside, but spot is 5.6% above nearest max pain ($125), creating a conflict between mechanical drift and dealer hedging pressure. Mixed flow and high IV add noise.
Conflicts: Spot ($122.78) well above max pain ($125-$130 near-term), net premium +$2.2M slightly bullish vs. negative GEX.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $-7.0M
DEX: +8.7M shares
Gamma flip: ~$105 (Approx — based on put OI concentration of 8,655)
NTM gamma: Dealers are net short gamma overall. A move below ~$105 (gamma flip) could accelerate selling as dealers sell to hedge. A move higher would see them buy to cover, providing less stabilizing force.
IV Analysis
IV vs VIX: IV 58.4% — extremely elevated, implying expensive options. Selling premium has inherent edge, but negative GEX increases risk.
Term structure: Humped — IV peaks at 61.0% for the 5/8 expiry (38 DTE), then gradually declines. This kink may price in post-earnings uncertainty (est. 5/5).
Skew: Near-term (2d) IV at 53.3% vs. 10d at 50.4% offers a ~3 vol-pt drop — supports short-dated premium sales or calendars selling the 4/2 expiry.
Flow Analysis
Net premium: +$2.2M slightly bullish; P/C vol 0.97, P/C OI 0.96 — perfectly balanced, indicating no strong directional conviction.
Directional prints: Unusual $124P 4/10 vol 158 vs OI 100 (1.6x) at IV 47.3% — could be a protective put buy or a speculative short put. Given mixed regime, side is ambiguous.
Unusual: Massive premium flow in deep OTM calls ($67.50, $35) and puts ($170, $195) — indicative of speculative, low-delta positioning or structured product flow, not near-term directional bets.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long stock | Weak | N/A | Negative GEX and spot above MP favor downside. High IV makes covered calls better. |
| Short stock | Moderate | N/A | Negative GEX supports, but strong $105 put floor and high borrow cost limit upside. |
| Covered call | Moderate-Strong | Own stock, sell $130C 4/17 or $135C 5/1. | Stock drifts to max pain; capped upside if rally breaks above OI wall. |
| Cash-secured put / put spread | Moderate | Sell $115/$110 put spread 4/17 (above put floor, below spot). | Negative GEX increases chance of hitting strikes; defined risk via spread. |
| Long calls | Weak | N/A | High IV (58.4%) is punitive for buyers; negative GEX and spot above MP are headwinds. |
| Long puts / bear put spread | Moderate-Strong | Buy $125/$120 bear put spread 4/10 (targeting move to weekly MP). | High IV still a cost, but negative GEX and downward pin provide directional edge. |
| Iron condor | Moderate-Weak | e.g., $115/$110P x $135/$140C 4/17. | GEX negative (trending) violates core range-bound assumption; VIX context unknown but high IV helps. |
| Calendar/diagonal | Moderate | Sell 4/2 $125C (IV 53.3%), buy 4/17 $125C (IV 50.7%) — reverse calendar for bearish/bias. | Captures IV drop; short leg benefits from pin to $125. Directional assumption required. |
| PMCC / LEAPS diagonal | Moderate | Buy 2027 $105 LEAPS (IV ~55%), sell 4/17 $130C against it. | Long-dated IV high, but provides leverage for a grind toward max pain with income. |
Top Plays
Watchlist Triggers
Tactical Summary
Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.
Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.
These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.